$VEEV

After $12.8M in sales, Veeva (NYSE: VEEV) executive files notice for another stock sale

Veeva Systems (VEEV) officer Thomas D. Schwenger filed a Rule 144 notice to sell 3,000 shares worth $787,200. He previously sold 51,000 shares for $12.8M via 10b5-1 plans in the past three months. VEEV has 161.9M shares outstanding.

Original reporting
Published Sep 14, 2026, 9:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 1:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$VEEV
Neutral
medium confidence
Mentioned
$VEEV
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$VEEVNeutralLow
01

Why it matters

The Rule 144 filing is a routine disclosure of insider liquidity. While it adds supply, the amount is modest relative to float, so market impact is expected to be limited.

02

Market read

A small, routine insider sale with limited price impact; primarily of interest to short‑term traders monitoring supply changes.

03

What to watch

The cumulative $12.8M sold in the past three months may indicate a broader liquidity strategy.

Relevance 4/10Novelty 4/10Timing: today

Background

Veeva Systems (NYSE: VEEV) provides cloud software for the life‑sciences industry. Insider sales are disclosed via Form 4 filings.

Company-level read

Ticker impact

$VEEVNeutralMedium confidence
Context

Officer Thomas D. Schwenger filed a Rule 144 notice to sell 3,000 VEEV shares worth $787,200, a new insider sale filing.

Expected impact

Limited downside risk; price may dip slightly if market perceives insider selling as negative.

Evidence & confidence

Sale represents <0.2% of outstanding shares and follows prior 10b5‑1 sales, suggesting routine liquidity need rather than loss of confidence.

Market effects

Minimal; Veeva operates in cloud‑based life‑sciences software, and a small insider sale does not affect sector outlook.

None

Low

Counterpoint

If the insider sale signals upcoming negative news, the stock could face sharper pressure.

Key entities

  • Thomas D. Schwenger

    Veeva executive filing the Rule 144 notice.

Related articles

$VEEVMed

CFRA upgrades Veeva Systems (VEEV) to a Buy

CFRA upgraded Veeva Systems (VEEV) to Buy with a new price target. The consensus rating is Moderate Buy with an average target of $293.57. Veeva reported Q2 revenue of $927.96M and net profit of $273.43M, up from $789.08M and $200.31M last year. Insider sentiment is negative, with 63 insiders selling shares.

$VEEVHighAI 8/10

Michael Burry Remains Bullish on Veeva but Trimmed His Position. What This Means for VEEV Stock.

Veeva Systems reported a 37% increase in net income to $273.4M and raised fiscal 2027 revenue guidance to $3.682B-$3.687B. Michael Burry trimmed his position but remains bullish, citing the company's intrinsic value and growth potential. Analysts expect Q3 EPS of $1.68 and have raised price targets, with a consensus 'Moderate Buy' rating and $292.52 average target.

$VEEVMedAI 8/10

Veeva Rises on Sales and Margin Gains, Guidance Raise

Veeva Systems (VEEV) reported Q2 fiscal 2027 revenue of $928M, up 18% YoY, with non-GAAP operating income of $415.9M. The company raised guidance to $3.687B in revenue and $9.21 in non-GAAP EPS. VEEV shares have risen 25% YTD, supported by strong institutional demand and robust fundamentals, including 3-year sales and EPS growth rates of 14.1% and 21.6%, respectively.

$VEEVHighAI 8/10

Watch Veeva, CrowdStrike, and More

Veeva Systems (VEEV) reported Q2 non-GAAP EPS of $2.35, revenue growth of 17.6% Y/Y to $928M, and raised its Q3 revenue forecast. CrowdStrike (CRWD) posted 25.6% Y/Y revenue growth to $1.47B. Dycom Industries (DY) fell 11.6% despite 45.6% Y/Y revenue growth to $2.01B due to segment pressures and higher costs.

$VEEVHighAI 8/10

Veeva (VEEV) Q2 2027 Earnings Call Transcript

Veeva Systems (VEEV) reported Q2 2027 revenues of $928.0 million, up 18% YoY, driven by growth in commercial and R&D segments. Subscription revenues rose 16% to $766.8 million. Non-GAAP operating income was $415.9 million, with a 44.8% margin. The company raised FY 2027 revenue guidance to $3.682B-$3.687B and EPS guidance to $9.21. Management highlighted strong adoption of Vault CRM and Data Cloud solutions, with 12 top 20 biopharmas committed to Vault CRM. Risks include the launch of the new Fa